New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design
Twenty lupane type A-ring azepano-triterpenoids were synthesized from betulin and its related derivatives and their antitubercular activity against <i>Mycobacterium tuberculosis</i>, mono-resistant MTB strains, and nontuberculous strains <i>Mycobacterium abscessus</i> and Myc...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e7403c52ff547d18f5dcf6d20eacf42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3e7403c52ff547d18f5dcf6d20eacf42 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3e7403c52ff547d18f5dcf6d20eacf422021-11-25T17:57:38ZNew Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design10.3390/ijms2222125421422-00671661-6596https://doaj.org/article/3e7403c52ff547d18f5dcf6d20eacf422021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12542https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Twenty lupane type A-ring azepano-triterpenoids were synthesized from betulin and its related derivatives and their antitubercular activity against <i>Mycobacterium tuberculosis</i>, mono-resistant MTB strains, and nontuberculous strains <i>Mycobacterium abscessus</i> and Mycobacterium <i>avium</i> were investigated in the framework of AToMIc (Anti-mycobacterial Target or Mechanism Identification Contract) realized by the Division of Microbiology and Infectious Diseases, NIAID, National Institute of Health. Of all the tested triterpenoids, 17 compounds showed antitubercular activity and 6 compounds were highly active on the H37Rv wild strain (with MIC 0.5 µM for compound <b>7</b>), out of which 4 derivatives also emerged as highly active compounds on the three mono-resistant MTB strains. Molecular docking corroborated with a machine learning drug-drug similarity algorithm revealed that azepano-triterpenoids have a rifampicin-like antitubercular activity, with compound <b>7</b> scoring the highest as a potential <i>M. tuberculosis</i> RNAP potential inhibitor. FIC testing demonstrated an additive effect of compound <b>7</b> when combined with rifampin, isoniazid and ethambutol. Most compounds were highly active against <i>M. avium</i> with compound <b>14</b> recording the same MIC value as the control rifampicin (0.0625 µM). The antitubercular ex vivo effectiveness of the tested compounds on THP-1 infected macrophages is correlated with their increased cell permeability. The tested triterpenoids also exhibit low cytotoxicity and do not induce antibacterial resistance in MTB strains.Oxana KazakovaRoxana RacoviceanuAnastasiya PetrovaMarius MiocAdrian MilitaruLucreția UdrescuMihai UdrescuAdrian VoicuJason CummingsGregory RobertsonDiane J. OrdwayRichard A. SlaydenCodruța ȘoicaMDPI AGarticletriterpenoidslupanebetulinazepane<i>M. tuberculosis</i>resistant MTB strainsBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12542, p 12542 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
triterpenoids lupane betulin azepane <i>M. tuberculosis</i> resistant MTB strains Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
triterpenoids lupane betulin azepane <i>M. tuberculosis</i> resistant MTB strains Biology (General) QH301-705.5 Chemistry QD1-999 Oxana Kazakova Roxana Racoviceanu Anastasiya Petrova Marius Mioc Adrian Militaru Lucreția Udrescu Mihai Udrescu Adrian Voicu Jason Cummings Gregory Robertson Diane J. Ordway Richard A. Slayden Codruța Șoica New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design |
description |
Twenty lupane type A-ring azepano-triterpenoids were synthesized from betulin and its related derivatives and their antitubercular activity against <i>Mycobacterium tuberculosis</i>, mono-resistant MTB strains, and nontuberculous strains <i>Mycobacterium abscessus</i> and Mycobacterium <i>avium</i> were investigated in the framework of AToMIc (Anti-mycobacterial Target or Mechanism Identification Contract) realized by the Division of Microbiology and Infectious Diseases, NIAID, National Institute of Health. Of all the tested triterpenoids, 17 compounds showed antitubercular activity and 6 compounds were highly active on the H37Rv wild strain (with MIC 0.5 µM for compound <b>7</b>), out of which 4 derivatives also emerged as highly active compounds on the three mono-resistant MTB strains. Molecular docking corroborated with a machine learning drug-drug similarity algorithm revealed that azepano-triterpenoids have a rifampicin-like antitubercular activity, with compound <b>7</b> scoring the highest as a potential <i>M. tuberculosis</i> RNAP potential inhibitor. FIC testing demonstrated an additive effect of compound <b>7</b> when combined with rifampin, isoniazid and ethambutol. Most compounds were highly active against <i>M. avium</i> with compound <b>14</b> recording the same MIC value as the control rifampicin (0.0625 µM). The antitubercular ex vivo effectiveness of the tested compounds on THP-1 infected macrophages is correlated with their increased cell permeability. The tested triterpenoids also exhibit low cytotoxicity and do not induce antibacterial resistance in MTB strains. |
format |
article |
author |
Oxana Kazakova Roxana Racoviceanu Anastasiya Petrova Marius Mioc Adrian Militaru Lucreția Udrescu Mihai Udrescu Adrian Voicu Jason Cummings Gregory Robertson Diane J. Ordway Richard A. Slayden Codruța Șoica |
author_facet |
Oxana Kazakova Roxana Racoviceanu Anastasiya Petrova Marius Mioc Adrian Militaru Lucreția Udrescu Mihai Udrescu Adrian Voicu Jason Cummings Gregory Robertson Diane J. Ordway Richard A. Slayden Codruța Șoica |
author_sort |
Oxana Kazakova |
title |
New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design |
title_short |
New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design |
title_full |
New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design |
title_fullStr |
New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design |
title_full_unstemmed |
New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design |
title_sort |
new investigations with lupane type a-ring azepane triterpenoids for antimycobacterial drug candidate design |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/3e7403c52ff547d18f5dcf6d20eacf42 |
work_keys_str_mv |
AT oxanakazakova newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT roxanaracoviceanu newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT anastasiyapetrova newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT mariusmioc newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT adrianmilitaru newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT lucretiaudrescu newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT mihaiudrescu newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT adrianvoicu newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT jasoncummings newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT gregoryrobertson newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT dianejordway newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT richardaslayden newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign AT codrutasoica newinvestigationswithlupanetypearingazepanetriterpenoidsforantimycobacterialdrugcandidatedesign |
_version_ |
1718411796179582976 |